|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 9 studies with search of: | lymphoma OR CLL | abt-263 |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Assess the Oral Bioavailability of a New ABT-263 Formulation in Subjects With Cancer
|
||||
| 2 | Recruiting |
A Study Evaluating ABT-263 With Erlotinib, ABT-263 With Irinotecan, and ABT-263 Monotherapy in Cancer Subjects
|
||||
| 3 | Recruiting |
A Phase 1 Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of ABT-263
|
||||
| 4 | Active, not recruiting |
Oral Bioavailability and Pharmacokinetics (PK) Study of the Capsule Formulation of ABT-263 in Cancer
|
||||
| 5 | Recruiting |
A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
|
||||
| 6 | Not yet recruiting |
Study Assessing the Safety and Efficacy of ABT-263 in Subjects With B-cell Chronic Lymphocytic Leukemia (CLL) Who Have Failed at Least One Prior Fludarabine-containing Regimen
|
||||
| 7 | Completed |
Pharmacokinetics of Liquid vs. Capsule Form of ABT-263
|
||||
| 8 | Recruiting |
Study of ABT-263 When Administered in Combination With Either Fludarabine/Cyclophosphamide/Rituximab or Bendamustine/Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
|
||||
| 9 | Recruiting |
A Phase 1/2a Study of ABT-263 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia
|